Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call
April 20, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., April 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors
April 14, 2021 17:15 ET
|
Neuronetics
MALVERN, Pa., April 14, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Announces Appointment of Robert Cascella to its Board of Directors
April 01, 2021 16:05 ET
|
Neuronetics
MALVERN, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical
March 11, 2021 16:25 ET
|
Neuronetics
MALVERN, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Enhances TrakStar® Cloud Patient Data Management System to Maximize Physician Efficiencies
March 09, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Names Cory Anderson Vice President, Clinical Affairs and Medical Operations
March 03, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., March 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
March 02, 2021 07:30 ET
|
Neuronetics
MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NeuroStar® Advanced Therapy Outcomes Registry Clinical Data Published in Brain Stimulation Validates Depression Treatment Protocols
February 23, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call
February 16, 2021 07:00 ET
|
Neuronetics
MALVERN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Announces Strategic Leadership Promotions to Support Future Growth
February 11, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...